Brief Overview of Front-line treatment for Mantel Cell Lymphoma in Older Patients

Opinion
Video

Key opinion leaders examine the current frontline treatment options for mantle cell lymphoma while identifying critical unmet patient needs requiring attention.

Recent Videos
Jose Sandoval Sus, MD, discussed standard CAR T-cell therapies in patients across multiple high-risk lymphoma indications.
5 experts are featured in this series
4 experts in this video
4 experts in this video
4 experts in this video
5 experts are featured in this series
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, MD.
2 experts are featured in this series.
2 experts are featured in this series.
1 expert is featured in this series.
Related Content